Cyproheptadine antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-Cyproheptadine antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to food safety diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-140-11. BSA-Cyproheptadine
2. Anti-Cyproheptadine mouse monoclonal antibody
$2709.00
GMP-SMT-140-21. OVA-Cyproheptadine
2. Anti-Cyproheptadine mouse monoclonal antibody
$2709.00
GMP-SMT-140-31. BSA-Cyproheptadine
2. Anti-Cyproheptadine human monoclonal antibody
$2709.00
GMP-SMT-140-41. OVA-Cyproheptadine
2. Anti-Cyproheptadine human monoclonal antibody
$2709.00
GMP-SMT-140-Ag-1BSA-Cyproheptadine$756.00
GMP-SMT-140-Ag-2OVA-Cyproheptadine$756.00
GMP-SMT-140-Ab-1Anti-Cyproheptadine mouse monoclonal antibody$1953.00
GMP-SMT-140-Ab-2Anti-Cyproheptadine human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-Cyproheptadine

Cat No.GMP-SMT-140-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Cyproheptadine with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Cyproheptadine had been validated with our anti-Hapten antibody Anti-Cyproheptadine mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-Cyproheptadine

Cat No.GMP-SMT-140-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-Cyproheptadine with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Cyproheptadine had been validated with our anti-Hapten antibody Anti-Cyproheptadine mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Cyproheptadine mouse monoclonal antibody

Cat No.GMP-SMT-140-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.1-0.2
Products descriptionThe anti-Hapten antibody against hapten Cyproheptadine had been validated with our hapten hapten-carrier conjugates BSA-Cyproheptadine via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Cyproheptadine human monoclonal antibody

Cat No.GMP-SMT-140-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.1-0.2
Products descriptionThe anti-Hapten antibody against hapten Cyproheptadine had been validated with our hapten hapten-carrier conjugates BSA-Cyproheptadine via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Biomarker Information


    Cyproheptadine Description:

    Cyproheptadine, a pharmacological compound belonging to the class of first-generation antihistamines and serotonin antagonists, is renowned for its unique ability to selectively block histamine and serotonin receptors. Its pharmacological properties make it a valuable asset in the realm of biopharmaceuticals, particularly in the management of allergic reactions and the mitigation of inflammatory responses. Within the context of environmental applications, Cyproheptadine assumes a pivotal role in addressing the impact of environmental factors on allergic conditions and inflammatory processes.

    Environmental Role:

    The significance of Cyproheptadine in environmental scenarios is closely tied to its capacity to modulate allergic responses and inflammation elicited by environmental factors. Environmental allergens, including pollen, dust mites, animal dander, and mold spores, have the potential to provoke the release of histamine and other inflammatory mediators within individuals susceptible to allergies. Cyproheptadine, acting as an antagonist, intercepts these allergenic signals by binding to histamine receptors, thereby reducing the severity of allergic symptoms and inflammatory responses. This unique characteristic positions Cyproheptadine as a valuable tool for addressing environmental allergies and mitigating their impact on affected individuals.

    Reasons to Measure Cyproheptadine:

    The precise measurement of Cyproheptadine serves several essential purposes, particularly within the realm of a biopharmaceutical company specializing in anti-small molecules antibodies and small molecules competitive antigens:

    a. Allergy Management:

    Cyproheptadine plays a crucial role in the management of environmental allergies, offering relief from distressing symptoms such as sneezing, itching, nasal congestion, and watery eyes. The accurate measurement of Cyproheptadine ensures the administration of the appropriate dosage to effectively alleviate allergic symptoms and improve the quality of life for individuals exposed to environmental allergens.

    b. Research and Development:

    In the biopharmaceutical sector, Cyproheptadine serves as a versatile tool, potentially employed as an immunogen, carrier-coupled antigen, or hapten-carrier conjugate for a diverse range of applications. This includes the development of therapeutic interventions aimed at mitigating allergic conditions. Precise measurement of Cyproheptadine is pivotal during the research and development phase, ensuring the potency and efficacy of these therapeutic products. It facilitates the creation of novel treatments that target allergic responses with precision.

    c. Environmental Assessment:

    The quantification of Cyproheptadine can be of significant relevance in environmental monitoring endeavors. Researchers may use Cyproheptadine measurement to assess the presence and levels of Cyproheptadine in environmental samples, providing insights into its potential impact on ecosystems and wildlife. Understanding the distribution and persistence of Cyproheptadine in the environment can aid in evaluating its ecological implications.

    d. Quality Assurance:

    For pharmaceutical companies engaged in the production of medications containing Cyproheptadine, rigorous quality assurance measures are paramount. Consistency in product quality and efficacy is essential. Accurate measurement of Cyproheptadine content is pivotal for ensuring compliance with stringent regulatory standards and upholding the highest levels of product quality. Quality control measures in the pharmaceutical industry rely on precise analytical techniques to maintain the integrity of medicinal products.

    e. Clinical Applications:

    Within clinical settings, Cyproheptadine serves as a therapeutic agent in the treatment of various medical conditions. It finds application in addressing allergies, migraine headaches, serotonin syndrome, and other related ailments. Precise measurement is vital to determine the appropriate dosages for individual patients, ensuring their safety and the effectiveness of the treatment regimen. Clinicians rely on accurate Cyproheptadine measurement to tailor treatments to the specific needs of each patient.

    In summary, the meticulous measurement of Cyproheptadine holds paramount importance in diverse domains, including the management of allergies, advancement of research and development initiatives, assessment of environmental impact, maintenance of pharmaceutical product quality, and optimization of clinical applications. Accurate quantification of Cyproheptadine is instrumental in ensuring product safety, efficacy, and compliance across the pharmaceutical and environmental sectors, as well as in improving the well-being of individuals affected by allergies and related conditions.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.